Clinical trialNCT02889900CompletedPhase 2Interventional

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

SponsorAstraZenecaEnrollment62Recurrent Platinum Resistant Ovarian Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jung-Min Lee, M.D.
NIH - National Cancer Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Mobile, Alabama, United States
Research Site
Anchorage, Alaska, United States
Research Site
Downey, California, United States
Research Site
Greenbrae, California, United States
Research Site
Orange, California, United States
Research Site
San Diego, California, United States
Research Site
San Francisco, California, United States
Research Site
West Hollywood, California, United States
Research Site
Miami, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Augusta, Georgia, United States
Research Site
Newnan, Georgia, United States
Research Site
Fort Wayne, Indiana, United States
Research Site
Westwood, Kansas, United States
Research Site
Covington, Louisiana, United States
Research Site
Towson, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Billings, Montana, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Knoxville, Tennessee, United States
Research Site
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Jan 2017
Primary completion: 27 Aug 2019
Completion: 16 Mar 2021
Last update posted: 8 Mar 2022
Registered enrollment: 62
Registry id: NCT02889900

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.